Drug shows promise against vision-robbing disease in seniors

  • Jun. 21, 2017 12:30 a.m.

WASHINGTON — An experimental drug is showing promise against an untreatable eye disease that blinds older adults — and intriguingly, it seems to work in patients who carry a particular gene flaw that fuels the damage to their vision.

Age-related macular degeneration, or AMD, is the leading cause of vision loss among seniors, gradually eroding crucial central vision. There are different forms but more than 5 million people worldwide, and a million in the U.S., have an advanced type of so-called “dry” macular degeneration that has no treatment. First patients may notice blurriness when they look straight ahead. Eventually many develop blank spots, becoming legally blind.

“These are seniors who are entering their golden years and now they’ve lost the ability to read, watch television, see their loved ones,” said Dr. Rahul Khurana, a retina specialist and spokesman for the American Academy of Ophthalmology.

The experimental drug, lampalizumab, aims to slow the destruction of light-sensing cells in the retina, creeping lesions that characterize the stage of dry AMD called “geographic atrophy.” When those cells die, they can’t grow back — the vision loss is irreversible.

WHAT THE RESEARCH FOUND

In an 18-month study of 129 patients, monthly eye injections of the drug modestly slowed worsening of the disease when compared with patients given dummy shots. What’s exciting for scientists came next, when researchers from drugmaker Genentech Inc. took a closer look at exactly who was being helped.

It turns out that nearly 6 in 10 of the study’s participants carry a gene variation that makes part of the immune system go awry — a genetic flaw already known to increase the risk of getting macular degeneration in the first place.

Those are the only patients who appeared to benefit from the drug; they had 44 per cent less eye damage than the untreated patients, the Genentech team reported Wednesday in the journal Science Translational Medicine. While the study is too small to prove if lampalizumab really helps maintain vision, that’s a bigger difference than the overall results suggested.

WHY WOULD AN IMMUNE-RELATED GENE AFFECT AGING EYES?

One arm of the immune system, the complement pathway, helps fight infections by attracting immune cells to attack bacteria.

Normally, there’s a barrier that keeps such cells away from the retina. But that barrier can break down with age, opening sensitive eye cells to harm from the spillover, explained Genentech immunologist Menno van Lookeren Campagne.

Now for the gene connection: Previous studies have linked macular degeneration to gene variations that remove some of that pathway’s natural brakes, so it can become too active.

The hypothesis: Genentech’s drug, lampalizumab, essentially offers a backup method for tamping down the immune reaction. An antibody, it works by inhibiting a particular enzyme named factor D that helps power the immune pathway.

“We try to reinsert the braking ability,” said study lead author Brian Yaspan, a Genentech senior scientist.

WHAT’S NEXT

Wednesday’s study detected no safety concerns, clearing the way for Genentech and its parent company Roche to open two large-scale studies that aim to prove if the drug works. Results are expected later this year.

The current research sheds light on how that long-suspected immune culprit might be working, and is “the first suggestion that there may be a treatment for geographic atrophy coming up in the future,” said National Eye Institute retina specialist Dr. Wai Wong, who wasn’t involved in the study.

“It’s a very, very exciting study,” said Khurana, the ophthalmologist association’s spokesman, who also wasn’t part of the research. “From the basic science perspective, it makes a lot of sense.”

HEALTH ADVICE FOR NOW

Macular degeneration tends to occur after age 60, but it sometimes strikes earlier. According to the National Eye Institute, it’s less common in people who exercise regularly, avoid smoking, and eat a diet high in green leafy vegetables and fish.

Symptoms often aren’t noticeable early on. But several eye tests can detect signs of macular degeneration, including a dilated eye exam and a tool called an Amsler grid with straight lines that may look wavy if the macula, the centre of the retina, is harmed.

Macular degeneration patients often are advised to take certain vitamin combinations that may help stave off advanced disease. And it’s important for patients to know what type they have. While there’s no treatment for the advanced dry form, the “wet” form occurs when leaky blood vessels grow under the retina — and there are several therapies that can help those patients preserve vision.

Just Posted

BREAKING: Red Deer to host Canadian Finals Rodeo in 2018

The CFR is expected to bring $20-30 million annually to Red Deer and region

Canada, U.S. lead call for enforcement of sanctions against North Korea

VANCOUVER — Canada and the U.S. led calls Tuesday for the global… Continue reading

Donald Trump aces mental aptitude test designed by an immigrant to Canada

WASHINGTON — When the White House released the results of a test… Continue reading

Food industry fails to meet most voluntary sodium reduction targets: Health Canada

TORONTO — Voluntary sodium targets for the food industry have failed to… Continue reading

Feds long way from restarting or scraping missing, murdered women inquiry: PM

OTTAWA — Prime Minister Justin Trudeau says his government is a long… Continue reading

WATCH: Rebels play floor hockey with Annie L. Gaetz students

The Rebels may be on a losing streak but they were definitely… Continue reading

Ice dancers Virtue and Moir to carry flag at Pyeongchang Olympics

Not since Kurt Browning at the 1994 Lillehammer Games has a figure… Continue reading

Beer Canada calls on feds to axe increasing beer tax as consumption trends down

OTTAWA — A trade association for Canada’s beer industry wants the federal… Continue reading

Central Albertans recall Hawaii’s false missile alert

Former Red Deer councillor Paul Harris was hanging out at the Ka’anapali… Continue reading

This robotic maid takes us one step closer to ‘The Jetsons’

Imagine this: You’re rushing to get ready for work — juggling emails,… Continue reading

Milan line offers canine couture for pampered pooches

Milan has long been the world’s ready-to-wear fashion leader. Now, dogs are… Continue reading

Kim Kardashian West and husband Kanye welcome baby girl

NEW YORK — It’s a girl for Kim Kardashian West and her… Continue reading

Advocate poll takers oppose plastic bag ban

Red Deer Advocate readers like their plastic bags. In an Advocate poll,… Continue reading

Most Read


Five-day delivery plus unlimited digital access for $185 for 260 issues (must live in delivery area to qualify) Unlimited Digital Access 99 cents for the first four weeks and then only $15 per month Five-day delivery plus unlimited digital access for $15 a month